Report summary

Notifier

Name of person with notification obligation

Nils Anders Haegerstrand

Reason for notification

Closely associated

Person discharging managerial responsibilities

Nils Anders Haegerstrand

Position

Chief Executive Officer (CEO)/Managing Directory

Initial notification

Yes

Amendment

Details of amendment

Details of the Issuer/emission allowance market participant/auction platform/auctioneer/auction monitor

Name of issuer

Annexin Pharmaceuticals AB (publ)

Issuer’s LEI code

5493000JP703HGPJEX27

Details of transaction

Type of financial instrument	Financial instrument	ISIN code	Nature of transaction	Linked to a share option programme	Volume	Unit	Price per unit	Currency code	Transaction date	Place of the transaction
Subcription warrant	2020/2023		Acquisition		164,761	Quantity	0.32	SEK	07/01/2021	Outside a trading venue

Aggregation

Financial instrument	ISIN code	Nature of transaction	Transaction date	Place of the transaction	Volume	Weighted average price
2020/2023		Acquisition	07/01/2021	Outside a trading venue	164,761 (Quantity)	0.32 SEK
				Total:	164,761

<< Back